RemeGen Co., Ltd. — Board/Management Information 2020

Nov 5, 2020

==> picture [169 x 52] intentionally omitted <==

RemeGen Co., Ltd. 榮昌生物製藥（煙台）股份有限公司*

(the “Company”)

(A joint stock company incorporated in the People’s Republic of China with limited liability)

(Stock Code: 9995)

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

The members of the board of directors (the “ Board ”) of the Company are set out below:

Executive Directors

Mr. Wang Weidong (Chairman of the Board)

Dr. Fang Jianmin

Dr. He Ruyi

Mr. Lin Jian

Non-executive Directors

Dr. Wang Liqiang Dr. Su Xiaodi

Independent non-executive Directors

Ms. Yu Shanshan Mr. Hao Xianjing

Dr. Lorne Alan Babiuk

1

There are four Board committees. The composition of the Board committees is set out in the table below:

below:
CommitteeDirector	AuditCommittee	Remunerationand AppraisalCommittee	NominationCommittee	StrategyCommittee
Mr. WangWeidong	–	–	C	M
Dr. FangJianmin	–	–	–	C
Dr. He Ruyi	–	–	–	M
Mr. Lin Jian	–	M	–	–
Dr. WangLiqiang	M	–	–	M
Dr. Su Xiaodi	–	–	–	M
Ms. Yu Shanshan	M	C	M	–
Mr. Hao Xianjing	C	M	M	–
Dr. Lorne Alan Babiuk	–	–	–	M

Notes:

C Chairperson of the relevant Board committees M Member of the relevant Board committees

Hong Kong, November 6, 2020

• For identification purpose only

2